Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.24.3
Cover - shares
 9 Months Ended
Sep. 30, 2024
Nov. 13, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Sep. 30, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Entity Information [Line Items]    
Entity Registrant Name UNICYCIVE THERAPEUTICS, INC.  
Entity Central Index Key 0001766140  
Entity File Number 001-40582  
Entity Tax Identification Number 81-3638692  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 4300 El Camino Real  
Entity Address, Address Line Two Suite 210  
Entity Address, City or Town Los Altos  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94022  
Entity Phone Fax Numbers [Line Items]    
City Area Code (650)  
Local Phone Number 351-4495  
Entity Listings [Line Items]    
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol UNCY  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   103,796,406